How much credit should James Talarico receive for Texas’s $25 insulin copay cap?
Case period:
Published by The Dispute Index editorial teamPublished Updated
James Talarico says he capped Texas insulin costs at $25 a month. Lois Kolkhorst says she authored the 2021 law. Records document Talarico’s earlier bill and House sponsorship, making this a dispute over legislative credit.
Question in dispute
Talarico’s campaign says he introduced an earlier insulin-cap proposal, built bipartisan support, and was instrumental in S.B. 827’s passage.
Overview
S.B. 827’s enrolled version limits an enrollee’s cost sharing for a covered formulary insulin prescription to $25 per 30-day supply under specified health benefit plans; it is not a universal retail-price ceiling. The official bill history lists Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. Talarico’s H.B. 40, filed in November 2020, proposed a $100 monthly cap but did not advance out of committee. S.B. 827 began with a $50 cap and changed to $25 in a House committee report; the official record reviewed does not attribute that revision to a named individual.
Talarico’s January 2026 campaign advertisement says he “took on Big Pharma and capped insulin at $25 a month.” Kolkhorst replied that he did not author the bill that passed in 2021. In May 2021 House remarks, Talarico called the legislation a team effort and named Kolkhorst, Lucio, and Oliverson. The record documents distinct roles in a shared legislative effort, without establishing a single objective allocation of all political credit.
People in this case
James TalaricoDirectly involvedImage details
James Talarico speaking at a press conference at the Texas Capitol on January 13, 2025.
CC BY-SA 4.0
View original image (opens in a new tab)
Timeline
7 timeline entries on this page. Dates: November 9, 2020 to January 27, 2026
James Talarico files H.B. 40
Talarico filed H.B. 40, an insulin-cap proposal that set a $100 maximum per 30-day supply in its introduced text and later remained pending in committee.
Sources
Source details
Source details
Lois Kolkhorst files S.B. 827
Kolkhorst filed S.B. 827, which proposed a $50 insulin cost-sharing cap in its introduced version.
Sources
Source details
Source details
House committee reports substituted S.B. 827
The House Insurance Committee reported a substitute for S.B. 827 that contained the eventual $25 insulin cost-sharing limit; the official record does not assign the change to an individual.
Sources
Source details
Source details
Texas House passes amended S.B. 827
The Texas House passed S.B. 827 with the $25 cost-sharing provision. During floor remarks, Talarico described the legislation as a team effort.
Sources
Source details
Source details
Talarico campaign advertisement claims credit for $25 cap
A Talarico Senate-campaign advertisement says that he capped insulin at $25 a month while serving in the Texas House.
Sources
Source details
Kolkhorst disputes Talarico’s authorship of S.B. 827
Kolkhorst responds that Talarico did not author the bill that passed in 2021 and says she authored S.B. 827.
Sources
Source details
Source details
Talarico campaign responds to authorship dispute
A campaign spokesperson says Talarico was instrumental to S.B. 827’s passage and disputes claims that his role was not instrumental.
Sources
Source details
Claims
Claims separate what was said from what is contested. Follow each source for the original wording and context.
What was said
Attributed statement
James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Sources
Source details
“Insulin” — Talarico for TX Senate campaign advertisement00:00:15–00:00:20Source details
S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Attributed statement
Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Sources
Source details
Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758Source details
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
What's disputed
Disputed claim
Talarico’s campaign says he introduced an earlier insulin-cap proposal, built bipartisan support, and was instrumental in S.B. 827’s passage.
Talarico for Texas
Sources
Source details
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costsCampaign spokesperson statement; legislative-record reportingSource details
H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021Source details
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historySource details
Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 29 (printed p. 3793), lines 1175–1187
Arguments
Editorial analysis
Talarico’s documented role supports qualified credit
Limit of this argument
They do not show that he was the formal author of S.B. 827 or that he authored the $25 amount.
Read reasoning and sources
The official record shows that Talarico filed H.B. 40 before S.B. 827, served as a House sponsor of S.B. 827, and described the final effort as a team effort. Those facts support describing him as a participant in the legislative and advocacy effort that produced the cap.
Related claim
James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Sources
- H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
- Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 29 (printed p. 3793), lines 1175–1187
Editorial analysis
Kolkhorst’s formal authorship is documented
Limit of this argument
Formal authorship does not by itself measure every legislator’s advocacy, coalition-building, or political contribution to passage.
Read reasoning and sources
The official S.B. 827 history identifies Kolkhorst as the Senate author, while it identifies Lucio III and Talarico as House sponsors. The bill’s enacted $25 provision appears in the House committee report and enrolled text.
Related claim
Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Sources
- Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
- S.B. 827 — House committee report bill text§ 1358.103(b), House committee report version
- S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Response record
Responses
Latest recorded positions: 3. Dates: May 24, 2021 to January 27, 2026
Choose any combination. Selected filters stay active until you remove them or choose All responses.
3 responses on this page
Challenged the characterizationTalarico for TexasA Talarico campaign spokesperson said the campaign regarded Talarico as instrumental to S.B. 827’s passage and disputed statements that characterized his role as not instrumental. "Any assertion that he wasn’t instrumental to passing this bill is a flat-out lie."
Read context and sources
Responding to
Talarico’s campaign says he introduced an earlier insulin-cap proposal, built bipartisan support, and was instrumental in S.B. 827’s passage.
Why we used this label
The campaign explicitly disputes a characterization of Talarico’s role in the law’s passage.
Before the statement
Kolkhorst had said that Talarico did not author the bill that passed in 2021.
After the statement
The statement claims a meaningful advocacy role but does not provide a formal authorship record different from the official legislative history.
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costsCampaign spokesperson statement; legislative-record reportingH.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyTexas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 29 (printed p. 3793), lines 1175–1187Challenged the characterizationLois KolkhorstDirectly involvedKolkhorst said Talarico did not author the enacted 2021 bill and identified herself as S.B. 827’s author. "The truth is that you did not author the bill that passed in 2021."
Read context and sources
Responding to
Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Why we used this label
Kolkhorst challenges how Talarico’s campaign claim characterizes his formal role in the enacted legislation.
Before the statement
Talarico’s Senate-campaign advertisement said that he had capped insulin at $25 a month.
After the statement
The official legislative history lists Kolkhorst as the Senate author and Talarico as a House sponsor, leaving broader credit for advocacy and collaboration contested.
Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyMixed or conditional 
James TalaricoDirectly involvedDuring 2021 House-floor remarks on S.B. 827, Talarico described the insulin legislation as a team effort and named other lawmakers involved."This legislation has been a team effort."
Read context and sources
Responding to
James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Why we used this label
The remark describes a shared account of legislative credit. It does not condemn or defend any person’s conduct.
Before the statement
The Texas House was considering the Senate bill that would become the state’s insulin cost-sharing law.
After the statement
Talarico thanked Lucio, Kolkhorst, and Oliverson, and said several lawmakers had filed similar bills on the subject.
Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 29 (printed p. 3793), lines 1175–1187S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
Sources
“Insulin” — Talarico for TX Senate campaign advertisement
Original video
“Insulin” — Talarico for TX Senate campaign advertisement
Relevant passage: 00:00:15–00:00:20
Excerpt
"So when I got to the Texas House, I took on Big Pharma and capped insulin at $25 a month."
About this source
Thirty-second campaign advertisement. The cited line follows Talarico’s account of his Type 1 diabetes diagnosis and a $684 insulin prescription. The ad claims he helped achieve the cap but does not expressly say he was the sole author of the enacted legislation.
Source details
- Author
- James Talarico / Talarico for TX Senate
- Published
- Accessed
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costs
Reporting
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costs
Relevant passage: Campaign spokesperson statement; legislative-record reporting
Excerpt
"Any assertion that he wasn’t instrumental to passing this bill is a flat-out lie."
About this source
The Texas Tribune reports a statement from Talarico campaign spokesperson JT Ennis, as well as competing accounts of the bill's development.
Source details
- Author
- Kayla Guo
- Published
- Accessed
Texas House Journal — May 24, 2021, S.B. 827 remarks
Original text
Texas House Journal — May 24, 2021, S.B. 827 remarks
Relevant passage: PDF p. 29 (printed p. 3793), lines 1175–1187
Excerpt
"This legislation has been a team effort."
About this source
In official House-floor remarks on S.B. 827, Talarico described the effort as collaborative and thanked Lucio, Kolkhorst, and Oliverson. The journal preserves his contemporaneous characterization of roles, rather than independently resolving every participant's contribution.
Source details
- Author
- Texas House of Representatives
- Published
- Accessed
H.B. 40 — introduced bill text
Original text
H.B. 40 — introduced bill text
Relevant passage: § 1358.058(2), introduced version
Excerpt
"Not to exceed one hundred dollars per thirty-day supply of insulin."
About this source
Talarico's introduced H.B. 40 proposed a $100 limit per 30-day supply and other provisions. It shows he advanced an earlier insulin-cap proposal, but it was not the enacted S.B. 827 text.
Source details
- Author
- Texas Legislature Online
- Accessed
S.B. 827 — House committee report bill text
Original text
S.B. 827 — House committee report bill text
Relevant passage: § 1358.103(b), House committee report version
Excerpt
"The enrollee is required to pay exceeds $25 per prescription for a 30-day supply."
About this source
The House committee report version of S.B. 827 contains the $25 cost-sharing limit enacted later. The document does not assign the revision to a particular individual.
Source details
- Author
- Texas Legislature Online
- Accessed
Show fewer sources
S.B. 827 — introduced bill text
Original text
S.B. 827 — introduced bill text
Relevant passage: § 1358.103(b), introduced version
Excerpt
"The enrollee is required to pay exceeds $50 for a 30-day supply."
About this source
The introduced version of S.B. 827 names Kolkhorst and proposed a $50 cost-sharing limit. It establishes the bill's initial text, not who later shaped every revision.
Source details
- Author
- Texas Legislature Online
- Accessed
S.B. 827 — 87th Texas Legislature bill history
Original text
S.B. 827 — 87th Texas Legislature bill history
Relevant passage: 87(R) SB 827; author and sponsor fields; action history
Excerpt
"Author: Kolkhorst … Sponsor: Lucio III | Talarico."
About this source
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
Source details
- Author
- Texas Legislature Online
- Accessed
S.B. 827 — enrolled Texas bill text
Original text
S.B. 827 — enrolled Texas bill text
Relevant passage: § 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Excerpt
"A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply."
About this source
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
Source details
- Author
- Texas Legislature Online
- Accessed
H.B. 40 — 87th Texas Legislature bill history
Original text
H.B. 40 — 87th Texas Legislature bill history
Relevant passage: History page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021
Excerpt
"Relating to a cap on the monthly price of insulin and insulin supplies."
About this source
Official legislative history for Talarico’s H.B. 40. It establishes that he was an author of an earlier insulin-cap proposal and that the bill remained pending in committee rather than becoming the enacted $25 cost-sharing law.
Source details
- Author
- Texas Legislature Online
- Accessed
Lois Kolkhorst on authorship of Texas Senate Bill 827
Original post
Lois Kolkhorst on authorship of Texas Senate Bill 827
Excerpt
"The truth is that you did not author the bill that passed in 2021."
About this source
Kolkhorst’s direct response to Talarico’s January 2026 insulin advertisement. She identifies herself as the filer and author of SB 827; the post addresses formal bill authorship.
Source details
- Author
- Lois Kolkhorst
- Published
- Accessed
Corrections
(0)
Corrections address errors in our reporting or labels. When a speaker changes their position, we add a separate statement and link it to the earlier one.
No corrections on this page.